Metabolism is the battleground.

Metabolic capabilities determine which pathogens can infect specific hosts. This isn't random - it's a sophisticated contest where both sides deploy metabolic strategies to survive.

Host Defense

Your body starves invaders of nutrients.

Nutritional immunity - host sequestration of essential nutrients - shapes which pathogens can survive. Iron limitation creates severe acquisition pressure: bacteria need 0.05-2.0 × 10&sup-6; M, but bioavailable concentration is only 1.4 × 10&sup-9; M.

150+

Distinct siderophores evolved by pathogens

Zn + Mn

Chelated by calprotectin

ATP7A

Creates copper toxicity for pathogens

Pathogen Countermeasures

  • Siderophores: Iron-scavenging molecules with specific host compatibility
  • Metallophores: Specialized systems like staphylopine for multiple metals
  • Metal-independent enzymes: Bypass nutritional immunity entirely

Four distinct metabolic strategies.

Legionella: Engineering the Niche

~300 effectors

Actively constructs metabolic niches using the largest known bacterial effector arsenal. Auxotrophic for 7 amino acids, yet this vulnerability becomes a feature - synchronizing with host metabolic rhythms.

Rickettsia: Extreme Parasitism

51 host metabolites

Complete loss of glycolysis, pentose phosphate pathway, and most amino acid synthesis. ATP/ADP translocases enable direct energy parasitism - perhaps the most intimate metabolic coupling known.

Pseudomonas: Metabolic Versatility

190+ carbon sources

Five terminal oxidases plus complete denitrification. In CF lungs, shifts to anaerobic metabolism with phenazine production that maintains NAD+/NADH balance while generating toxic ROS.

Candida: Morphological Plasticity

Niche-specific adaptation

Crabtree-negative - maintains simultaneous glycolysis and respiration even in high glucose. Creates "Goliath cells" under zinc restriction. Glyoxylate cycle essential during macrophage phagocytosis.

Your immune cells are metabolic weapons.

Itaconate

Produced by activated macrophages at millimolar concentrations. Inhibits pathogen succinate dehydrogenase while modulating host inflammation. Delivered to pathogen-containing phagosomes via Rab32.

Warburg Effect

Aerobic glycolysis despite oxygen availability. Rapid ATP supports effector functions while depleting local glucose for pathogens. But many pathogens exploit this shift.

Succinate & Lactate

Succinate acts as danger signal through GPR91, stabilizing HIF-1α. Lactate creates immunosuppressive microenvironments through histone lactylation.

The "Goldilocks Strategy"

Conditions that are "just wrong" for pathogens - too little nutrients to thrive, too many toxic metabolites to survive, but optimal for host tissue preservation.

Barriers

Metabolic constraints prevent zoonotic spillover.

Amino Acid Auxotrophies

78.4% of bacteria retain complete biosynthetic capability, while auxotrophies concentrate in host-associated strains. Creates species-specific dependencies.

Sialic Acid Recognition

Humans uniquely lack Neu5Gc. Pathogens must recognize specific glycan patterns - influenza requires precise hemagglutinin-sialic acid linkage matching.

Microbiota as Barrier

The microbiota creates additional metabolic barriers through competitive exclusion. However, inflammation can paradoxically benefit certain pathogens - Salmonella exploits inflammation-associated tetrathionate as an alternative electron acceptor.

Targeting the metabolic interface.

Host-Directed Therapies

Metformin enhances immunity against tuberculosis through AMPK activation. Statins inhibit viral infections by disrupting lipid metabolism. Itaconate derivatives show broad-spectrum antimicrobial activity.

Siderophore-Antibiotic Conjugates

"Trojan horses" using bacterial iron uptake machinery to deliver antimicrobials. Effective against multi-drug resistant strains because siderophore systems are essential for virulence.

CRISPR-Identified Targets

Sphingolipid biosynthesis genes essential for EHEC infection. HMGB1 and SWI/SNF complexes support pan-coronavirus replication. Novel vulnerabilities without human equivalents.

Successful pathogens are metabolic engineers.

Rather than simple nutrient competition, we observe complex metabolic dialogues where information is encoded in metabolite concentrations and enzymatic activities signal cellular states. The future of infection control may lie in subtle metabolic interventions that turn dependencies into therapeutic opportunities.